|
|
 Previous Article | Table of Contents | Next Article 
Selective Ablation of Human T-Cell Lymphotropic Virus Type 1 p12I Reduces Viral Infectivity In Vivo
Nathaniel D. Collins,
Garret C. Newbound,
Björn Albrecht,
Jennifer L. Beard,
Lee Ratner, and
Michael D. Lairmore
From the Center for Retrovirus Research and the Department of
Veterinary Biosciences, The Ohio State University, Columbus, OH; the
Departments of Medicine, Pathology, and Molecular Microbiology,
Washington University School of Medicine, St Louis, MO; and the
Comprehensive Cancer Center, The Arthur James Cancer Hospital and
Research Institute, The Ohio State University, Columbus, OH.
Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiologic
agent of adult T-cell leukemia and HTLV-1-associated myelopathy. Novel,
yet conserved RNA transcripts encoded from open reading frames (ORFs) I
and II of the viral pX region are expressed both in vitro and in
infected individuals. The ORF I mRNA encodes the protein
p12I, which has been shown to localize to cellular
endomembranes, cooperate with bovine papillomavirus E5 in
transformation, as well as bind to the IL-2 receptor  and  chains
and the H+ vacuolar ATPase. It is unknown what role
p12I plays in the viral life cycle. Using an infectious
molecular clone of HTLV-1 (ACH) and a derivative clone,
ACH.p12I, which fails to produce the p12I
message, we investigated the importance of p12I in infected
primary cells and in a rabbit model of the infection. ACH.p12I was infectious in vitro as shown by viral passage
in culture and no qualitative or quantitative differences were noted
between ACH and ACH.p12I in posttransfection viral antigen
production. However, in contrast to ACH, ACH.p12I failed to
establish persistent infection in vivo as indicated by reduced
anti-HTLV-1 antibody responses, failure to demonstrate viral p19
antigen production in peripheral blood mononuclear cell (PBMC)
cultures, and only transient detection of provirus by polymerase chain
reaction in PBMC from ACH.p12I-inoculated rabbits. These
results are the first to show the essential role of HTLV-1
p12I in the establishment of persistent viral infection in
vivo and suggest potential new targets in antiviral strategies to
prevent HTLV-1 infection.
Blood, Vol. 91 No. 12 (June 15), 1998:
pp. 4701-4707
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Li, M. Kesic, H. Yin, L. Yu, and P. L. Green
Kinetic Analysis of Human T-Cell Leukemia Virus Type 1 Gene Expression in Cell Culture and Infected Animals
J. Virol.,
April 15, 2009;
83(8):
3788 - 3797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Arnold, B. Zimmerman, M. Li, M. D. Lairmore, and P. L. Green
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
Blood,
November 1, 2008;
112(9):
3788 - 3797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G P Taylor
Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma
J. Clin. Pathol.,
December 1, 2007;
60(12):
1392 - 1396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Banerjee, G. Feuer, and E. Barker
Human T-Cell Leukemia Virus Type 1 (HTLV-1) p12I Down-Modulates ICAM-1 and -2 and Reduces Adherence of Natural Killer Cells, Thereby Protecting HTLV-1-Infected Primary CD4+ T Cells from Autologous Natural Killer Cell-Mediated Cytotoxicity despite the Reduction of Major Histocompatibility Complex Class I Molecules on Infected Cells
J. Virol.,
September 15, 2007;
81(18):
9707 - 9717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Florins, N. Gillet, M. Boxus, P. Kerkhofs, R. Kettmann, and L. Willems
Even Attenuated Bovine Leukemia Virus Proviruses Can Be Pathogenic in Sheep
J. Virol.,
September 15, 2007;
81(18):
10195 - 10200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Chevalier, M. Walic, S. Calattini, A. Mallet, M.-C. Prevost, A. Gessain, and R. Mahieux
Construction and Characterization of a Full-Length Infectious Simian T-Cell Lymphotropic Virus Type 3 Molecular Clone
J. Virol.,
June 15, 2007;
81(12):
6276 - 6285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Asquith, Y. Zhang, A. J. Mosley, C. M. de Lara, D. L. Wallace, A. Worth, L. Kaftantzi, K. Meekings, G. E. Griffin, Y. Tanaka, et al.
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection
PNAS,
May 8, 2007;
104(19):
8035 - 8040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Miyazato, J.-i. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, and M. Matsuoka
De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice
J. Virol.,
November 1, 2006;
80(21):
10683 - 10691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Arnold, B. Yamamoto, M. Li, A. J. Phipps, I. Younis, M. D. Lairmore, and P. L. Green
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1
Blood,
May 15, 2006;
107(10):
3976 - 3982.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-j. Kim, A. M. Nair, S. Fernandez, L. Mathes, and M. D. Lairmore
Enhancement of LFA-1-Mediated T Cell Adhesion by Human T Lymphotropic Virus Type 1 p12I1
J. Immunol.,
May 1, 2006;
176(9):
5463 - 5470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hiraragi, S.-J. Kim, A. J. Phipps, M. Silic-Benussi, V. Ciminale, L. Ratner, P. L. Green, and M. D. Lairmore
Human T-Lymphotropic Virus Type 1 Mitochondrion-Localizing Protein p13II Is Required for Viral Infectivity In Vivo.
J. Virol.,
April 1, 2006;
80(7):
3469 - 3476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Xie, B. Yamamoto, A. Haoudi, O. J. Semmes, and P. L. Green
PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo
Blood,
March 1, 2006;
107(5):
1980 - 1988.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Younis, K. Boris-Lawrie, and P. L. Green
Human T-Cell Leukemia Virus Open Reading Frame II Encodes a Posttranscriptional Repressor That Is Recruited at the Level of Transcription
J. Virol.,
January 1, 2006;
80(1):
181 - 191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Younis, B. Yamamoto, A. Phipps, and P. L. Green
Human T-Cell Leukemia Virus Type 1 Expressing Nonoverlapping Tax and Rex Genes Replicates and Immortalizes Primary Human T Lymphocytes but Fails To Replicate and Persist In Vivo
J. Virol.,
December 1, 2005;
79(23):
14473 - 14481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Xie and P. L. Green
Envelope Is a Major Viral Determinant of the Distinct In Vitro Cellular Transformation Tropism of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2
J. Virol.,
December 1, 2005;
79(23):
14536 - 14545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Silverman, A. J. Phipps, A. Montgomery, S. Fernandez, T. Tsukahara, L. Ratner, and M. D. Lairmore
In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations
Blood,
November 15, 2005;
106(10):
3602 - 3608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Younis, L. Khair, M. Dundr, M. D. Lairmore, G. Franchini, and P. L. Green
Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator
J. Virol.,
October 15, 2004;
78(20):
11077 - 11083.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Silverman, A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion
J. Virol.,
April 15, 2004;
78(8):
3837 - 3845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Narayan, I. Younis, D. M. D'Agostino, and P. L. Green
Functional Domain Structure of Human T-Cell Leukemia Virus Type 2 Rex
J. Virol.,
December 1, 2003;
77(23):
12829 - 12840.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ye, L. Silverman, M. D. Lairmore, and P. L. Green
HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro
Blood,
December 1, 2003;
102(12):
3963 - 3969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Ding, S.-J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation
J. Virol.,
October 15, 2003;
77(20):
11027 - 11039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-j. Kim, W. Ding, B. Albrecht, P. L. Green, and M. D. Lairmore
A Conserved Calcineurin-binding Motif in Human T Lymphotropic Virus Type 1 p12I Functions to Modulate Nuclear Factor of Activated T Cell Activation
J. Biol. Chem.,
April 25, 2003;
278(18):
15550 - 15557.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Heidecker, S. Hill, P. A. Lloyd, and D. Derse
A Novel Protease Processing Site in the Transframe Protein of Human T-Cell Leukemia Virus Type 1 PR76gag-pro Defines the N Terminus of RT
J. Virol.,
November 13, 2002;
76(24):
13101 - 13105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Ding, B. Albrecht, R. E. Kelley, N. Muthusamy, S.-J. Kim, R. A. Altschuld, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells
J. Virol.,
September 11, 2002;
76(20):
10374 - 10382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. D'Agostino, L. Ranzato, G. Arrigoni, I. Cavallari, F. Belleudi, M. R. Torrisi, M. Silic-Benussi, T. Ferro, V. Petronilli, O. Marin, et al.
Mitochondrial Alterations Induced by the p13II Protein of Human T-cell Leukemia Virus Type 1. CRITICAL ROLE OF ARGININE RESIDUES
J. Biol. Chem.,
September 6, 2002;
277(37):
34424 - 34433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Albrecht and M. D. Lairmore
Critical Role of Human T-Lymphotropic Virus Type 1 Accessory Proteins in Viral Replication and Pathogenesis
Microbiol. Mol. Biol. Rev.,
September 1, 2002;
66(3):
396 - 406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Lefebvre, V. Ciminale, A. Vanderplasschen, D. D'Agostino, A. Burny, L. Willems, and R. Kettmann
Subcellular Localization of the Bovine Leukemia Virus R3 and G4 Accessory Proteins
J. Virol.,
June 27, 2002;
76(15):
7843 - 7854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Albrecht, C. D. D'Souza, W. Ding, S. Tridandapani, K. M. Coggeshall, and M. D. Lairmore
Activation of Nuclear Factor of Activated T Cells by Human T-Lymphotropic Virus Type 1 Accessory Protein p12I
J. Virol.,
March 7, 2002;
76(7):
3493 - 3501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Lefebvre, A. Vanderplasschen, V. Ciminale, H. Heremans, O. Dangoisse, J.-C. Jauniaux, J.-F. Toussaint, V. Zelnik, A. Burny, R. Kettmann, et al.
Oncoviral Bovine Leukemia Virus G4 and Human T-Cell Leukemia Virus Type 1 p13II Accessory Proteins Interact with Farnesyl Pyrophosphate Synthetase
J. Virol.,
February 1, 2002;
76(3):
1400 - 1414.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Ding, B. Albrecht, R. Luo, W. Zhang, J. R. L. Stanley, G. C. Newbound, and M. D. Lairmore
Endoplasmic Reticulum and cis-Golgi Localization of Human T-Lymphotropic Virus Type 1 p12I: Association with Calreticulin and Calnexin
J. Virol.,
August 15, 2001;
75(16):
7672 - 7682.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nicot, J. C. Mulloy, M. G. Ferrari, J. M. Johnson, K. Fu, R. Fukumoto, R. Trovato, J. Fullen, W. J. Leonard, and G. Franchini
HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells
Blood,
August 1, 2001;
98(3):
823 - 829.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Johnson, C. Nicot, J. Fullen, V. Ciminale, L. Casareto, J. C. Mulloy, S. Jacobson, and G. Franchini
Free Major Histocompatibility Complex Class I Heavy Chain Is Preferentially Targeted for Degradation by Human T-Cell Leukemia/Lymphotropic Virus Type 1 p12I Protein
J. Virol.,
July 1, 2001;
75(13):
6086 - 6094.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mandic, O. T. Fackler, M. Geyer, T. Linnemann, Y.-H. Zheng, and B. M. Peterlin
Negative Factor from SIV Binds to the Catalytic Subunit of the V-ATPase to Internalize CD4 and to Increase Viral Infectivity
Mol. Biol. Cell,
February 1, 2001;
12(2):
463 - 473.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
W. Zhang, J. W. Nisbet, J. T. Bartoe, W. Ding, and M. D. Lairmore
Human T-Lymphotropic Virus Type 1 p30II Functions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters
J. Virol.,
December 1, 2000;
74(23):
11270 - 11277.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. Albrecht, N. D. Collins, M. T. Burniston, J. W. Nisbet, L. Ratner, P. L. Green, and M. D. Lairmore
Human T-Lymphotropic Virus Type 1 Open Reading Frame I p12I Is Required for Efficient Viral Infectivity in Primary Lymphocytes
J. Virol.,
November 1, 2000;
74(21):
9828 - 9835.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Pique, A. Ureta-Vidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M.-C. Dokhelar
Evidence for the Chronic In Vivo Production of Human T Cell Leukemia Virus Type I Rof and Tof Proteins from Cytotoxic T Lymphocytes Directed against Viral Peptides
J. Exp. Med.,
February 7, 2000;
191(3):
567 - 572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Bartoe, B. Albrecht, N. D. Collins, M. D. Robek, L. Ratner, P. L. Green, and M. D. Lairmore
Functional Role of pX Open Reading Frame II of Human T-Lymphotropic Virus Type 1 in Maintenance of Viral Loads In Vivo
J. Virol.,
February 1, 2000;
74(3):
1094 - 1100.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. D. Collins, C. D'Souza, B. Albrecht, M. D. Robek, L. Ratner, W. Ding, P. L. Green, and M. D. Lairmore
Proliferation Response to Interleukin-2 and Jak/Stat Activation of T Cells Immortalized by Human T-Cell Lymphotropic Virus Type 1 Is Independent of Open Reading Frame I Expression
J. Virol.,
November 1, 1999;
73(11):
9642 - 9649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kucerova, V. Altanerova, C. Altaner, and K. Boris-Lawrie
Bovine Leukemia Virus Structural Gene Vectors Are Immunogenic and Lack Pathogenicity in a Rabbit Model
J. Virol.,
October 1, 1999;
73(10):
8160 - 8166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Koya, T. Ohashi, H. Kato, S. Hanabuchi, T. Tsukahara, F. Takemura, K.-i. Etoh, M. Matsuoka, M. Fujii, and M. Kannagi
Establishment of a Seronegative Human T-Cell Leukemia Virus Type 1 (HTLV-1) Carrier State in Rats Inoculated with a Syngeneic HTLV-1-Immortalized T-Cell Line Preferentially Expressing Tax
J. Virol.,
August 1, 1999;
73(8):
6436 - 6443.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Trovato, J. C. Mulloy, J. M. Johnson, S. Takemoto, M. P. de Oliveira, and G. Franchini
A Lysine-to-Arginine Change Found in Natural Alleles of the Human T-Cell Lymphotropic/Leukemia Virus Type 1 p12I Protein Greatly Influences Its Stability
J. Virol.,
August 1, 1999;
73(8):
6460 - 6467.
[Abstract]
[Full Text]
|
|
|
|
|
